Ensysce Biosciences Inc.

2.29
-0.35 (-13.26%)
At close: Apr 03, 2025, 3:58 PM
2.52
10.13%
After-hours: Apr 03, 2025, 07:43 PM EDT

Ensysce Biosciences Statistics

Share Statistics

Ensysce Biosciences has 1.41M shares outstanding. The number of shares has increased by 176.49% in one year.

Shares Outstanding 1.41M
Shares Change (YoY) 176.49%
Shares Change (QoQ) 7.68%
Owned by Institutions (%) 0%
Shares Floating 1.38M
Failed to Deliver (FTD) Shares 34
FTD / Avg. Volume 0.09%

Short Selling Information

The latest short interest is 6.35M, so 486.97% of the outstanding shares have been sold short.

Short Interest 6.35M
Short % of Shares Out 486.97%
Short % of Float 494.52%
Short Ratio (days to cover) 0.12

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.7. Ensysce Biosciences's PEG ratio is 0.

PE Ratio 0
Forward PE -0.7
PS Ratio 0
Forward PS 0.1
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ensysce Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.08.

Current Ratio 2.42
Quick Ratio 2.42
Debt / Equity 0.08
Debt / EBITDA -0.04
Debt / FCF -0.04
Interest Coverage 5.22

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1,141B
Employee Count 7
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -78.07% in the last 52 weeks. The beta is 0.65, so Ensysce Biosciences's price volatility has been higher than the market average.

Beta 0.65
52-Week Price Change -78.07%
50-Day Moving Average 5.18
200-Day Moving Average 6.3
Relative Strength Index (RSI) 23.43
Average Volume (20 Days) 36.23K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -6,730.1B
Net Income -7,987.2B
EBITDA -6,730.1B
EBIT -9,277.7B
Earnings Per Share (EPS) -4573049.94
Full Income Statement

Balance Sheet

The company has 3.5M in cash and 301.66B in debt, giving a net cash position of -301.66B.

Cash & Cash Equivalents 3.5M
Total Debt 301.66B
Net Cash -301.66B
Retained Earnings -129,544.3B
Total Assets 5.6M
Working Capital 3.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7,502.7B and capital expenditures 0, giving a free cash flow of -7,502.7B.

Operating Cash Flow -7,502.7B
Capital Expenditures 0
Free Cash Flow -7,502.7B
FCF Per Share -4295637.32
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENSC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ENSC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Dec 6, 2024. It was a backward split with a ratio of 1:15.

Last Split Date Dec 6, 2024
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -34.64
Piotroski F-Score 4